A Retrospective, Longitudinal Registry Study on the Long-Term Durability of Ivacaftor Treatment in People with Cystic Fibrosis

Abstract Introduction Ivacaftor (IVA) has been shown to change the trajectory of cystic fibrosis (CF) disease progression by slowing the rate of lung function decline in clinical studies. Long-term real-world data help to confirm the durability of this response. Methods This non-interventional, long...

Descrición completa

Detalles Bibliográficos

Principais autores:	Christian Merlo, Teja Thorat, Lisa J. McGarry, Christina V. Scirica, Maral DerSarkissian, Catherine Nguyen, Yuqian M. Gu, Aruna Muthukumar, Joe Healy, Jaime L. Rubin, M. Alan Brookhart
Formato:	Artigo
Idioma:	Inglês
Publicado:	Adis, Springer Healthcare 2024-09-01
Series:	Pulmonary Therapy
Assuntos:	CFTR modulator Cystic fibrosis Disease trajectory Ivacaftor Longitudinal study Lung function decline
Acceso en liña:	https://doi.org/10.1007/s41030-024-00269-9
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!